Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Body Dysmorphic Disorders”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 217 records · Page 12Linked to original sources
PubMed2006

Weight concerns in individuals with body dysmorphic disorder.

OBJECTIVE: To determine the prevalence of weight concerns in individuals with BDD, and to examine similarities and differences between those with and those without weight concerns. METHOD: We assessed 200 participants with BDD for clinically significant weight concerns and compared those with weight concerns (in addition to other body area concerns) to those without weight concerns on measures of BDD symptoms, other symptom severity, comorbidity, suicidality, functioning, and quality of life. RESULTS: 58 (29.0%) participants had weight concerns. Participants with weight concerns were younger, more likely to be female, and had more body areas of concern; a higher frequency of certain BDD behaviors, suicide attempts, and comorbidity; greater body image disturbance and depression; and poorer social functioning. The two groups were similar on other measures. DISCUSSION: Weight concerns in BDD deserve further study, as they appear relatively common and are associated with greater symptom severity and psychopathology in several domains.

Adolescent↗
PubMed1999

Body dysmorphic disorder in a Ghanaian male: case report.

A 39 year old single, unemployed man attended our outpatient clinic at the Accra Psychiatric Hospital. He was self referred and he presented with a characteristic preoccupation with some imagined defect in his appearance, namely the shrivelling of the whole left side of his body, which he claimed was severe enough to interfere with his social and occupational functioning. He was therefore admitted voluntarily for further exploration, examination and treatment. The diagnosis of body dysmorphophobic disorder was made. The literature review of this disorder, and the various attempts made at the treatment of the disorder have been described.

Adult↗
PubMedDate not supplied

Dysmorphophobia: body dysmorphic disorder or delusional disorder, somatic subtype?

The DSM-III-R proposes to divide dysmorphophobia into two separate disorders: delusional disorder, somatic subtype and dysmorphic disorder. We believe that this distinction of delusional and nondelusional is impossible from a phenomenological point of view, and that dysmorphophobic beliefs are better classified as overvalued ideas. The concept of dysmorphophobia and its relationship to monosymptomatic hypochondriacal psychoses and DSM-III-R categories is reviewed. A case report is described to support these arguments.

Adult↗
PubMed2006

Body dysmorphic disorder.

BDD remains an understudied psychiatric disorder. Further research is required to establish its etiopathology and neurocognitive underpinnings. Its relationship to other psychiatric disorders requires clarification. Also needed is a much better understanding of the best treatments to adopt should conventional approaches (eg, SRIs, CBT) fail.

Anxiety Disorders↗
PubMed2000

Body dysmorphic disorder.

The understanding of BDD and its treatment has expanded significantly in the past decade as controlled research has followed the leads from case reports and clinical experience. BDD is recognized as a severe, disabling disorder that is more common that had been assumed. Although BDD is still difficult to treat, success has been demonstrated for SRIs and CBT. Much remains to be discovered. To date, little is known about the causes and pathophysiology of BDD. Research that would illuminate these also would increase understanding of its relationship to other disorders, such as OCD, depression, and social phobia, and open up possibilities for prevention and new approaches to treatment. Investigations in brain imaging and genetics are underway. Research in pharmacotherapy and CBT, individually and combined, is needed to refine, extend, and optimize treatment.

Cognitive Behavioral Therapy↗